Company: IMRX
Filing Date: 2025-03-20
Form Type: 8-K
Source: 0001790340-25-000039
Chunk: 1

Company: Immuneering Corp
Filing Date: 2025-03-20
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

The following exhibits relate to Item 2.02, which shall be deemed to be furnished, and not filed:

  Exhibit      Description                                                                  
      No.                                                                                   
     99.1      Press Release issued on March 20, 2025                                       
 ────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                            IMMUNEERING CORPORATION                                                                                                        
  Date: March 20, 2025      By:                          /s/ Benjamin J. Zeskind                                                                           
                                                         Name: Benjamin J. Zeskind, Ph. D.                                                                 
                                                         Title: Co-Founder, President, Chief Executive Officer and Director (Principal Executive Officer)